Theranostics: A Unique Concept to Nuclear Medicine
Open Access
- 1 January 2017
- journal article
- Published by Heighten Science Publications Corporation
- Vol. 1 (1), 001-004
- https://doi.org/10.29328/journal.acst.1001001
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Options to meet the future global demand of radionuclides for radionuclide therapyNuclear Medicine and Biology, 2013
- Molecular Imaging and Radiotherapy: Theranostics for Personalized Patient ManagementTheranostics, 2012
- Molecular Theranostics: A Primer for the Imaging ProfessionalAmerican Journal of Roentgenology, 2011
- Somatostatin Receptors as Targets for Nuclear Medicine Imaging and Radionuclide TreatmentJournal of Nuclear Medicine, 2011
- Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICSDalton Transactions, 2011
- Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN)Cancer Research, 2011
- Transforming a Targeted Porphyrin Theranostic Agent into a PET Imaging Probe for CancerTheranostics, 2011
- PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examinationEuropean Journal of Radiology, 2010
- LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATINThe Lancet, 1989
- Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External PhotoscanningThe New England Journal of Medicine, 1978